[Endocrine treatment of metastasizing breast cancer in menopausal women. A randomized comparison between tamoxifen (Nolvadex) versus tamoxifen and medroxyprogesterone acetate (Clinovir)].
作者信息
Mouridsen H T, Ellemann K, Mattsson W, Palshof T, Daehnfeldt J, Rose C
出版信息
Ugeskr Laeger. 1979 Jul 30;141(31):2113-6.
PMID:483409
Abstract
摘要
相似文献
1
2
3
4
5
Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
Eur J Cancer (1965). 1980;Suppl 1:93-8.
6
Tamoxifen therapy of metastatic breast cancer.他莫昔芬治疗转移性乳腺癌。
J Lab Clin Med. 1987 Mar;109(3):290-9.
7
[Tamoxifen (Nolvadex): therapeutic effect in metastasizing breast cancer].[他莫昔芬（诺瓦得士）：对转移性乳腺癌的治疗效果]
Ugeskr Laeger. 1979 Jul 30;141(31):2108-13.
8
Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.转移性乳腺癌联合激素治疗（MAP + TAM）的临床试验。
Chemioterapia. 1984 Aug;3(4):211-5.
9
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
Am J Clin Oncol. 1982 Oct;5(5):495-9.
Zotero 插件